Patents by Inventor Su Wang

Su Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12647704
    Abstract: Embodiments of this application disclose an optical bus communication method, including: A first terminal obtains first control information from a controller, where the first control information is generated by the controller and is used to control an execution mechanism to work. The first terminal sends the first control information to a central office over a first section, so that the central office forwards the first control information to a second terminal, where the second terminal is connected to the execution mechanism. The first terminal obtains first state information from the central office, where the first state information is used to record a working state of the execution mechanism, the first state information is information sent by the second terminal to the central office over a second section after the second terminal obtains the first control information, and the first section does not overlap with the second section.
    Type: Grant
    Filed: August 24, 2023
    Date of Patent: June 2, 2026
    Assignee: HUAWEI TECHNOLOGIES CO., LTD.
    Inventors: Lun Zhang, Jun Luo, Su Wang
  • Publication number: 20260103742
    Abstract: The present disclosure relates in some aspects to methods, systems, and kits for analyzing a biological sample comprising performing extension of a target ribonucleic acid (RNA). In some aspects, RNA cutting enzyme and/or a nucleic acid oligonucleotide are used to generate a free 3? end of the target RNA for an extension reaction.
    Type: Application
    Filed: October 14, 2025
    Publication date: April 16, 2026
    Inventor: Su WANG
  • Publication number: 20260016706
    Abstract: The present application relates to an ophthalmic lens and frame eyeglasses comprising the lens. The ophthalmic lens includes a central portion, multiple first refractive regions, and multiple second refractive regions. The multiple first refractive regions are arranged in a first zone surrounding the central portion, while the multiple second refractive regions are arranged in a second zone farther away from the central portion compared to the first zone. The central portion has a prescription power based on the human eye, and the first and second refractive regions have different powers than the prescription power. Furthermore, the total area ratio of the multiple first refractive regions to the area of the first zone is greater than the total area ratio of the multiple second refractive regions to the area of the second zone. As a result, the present application allows for more effective management and control of myopia progression.
    Type: Application
    Filed: March 9, 2023
    Publication date: January 15, 2026
    Inventors: Yuxiao LIU, Su WANG, Tianrui HE, Yujing BAI
  • Patent number: 12489681
    Abstract: Some embodiments provide a method for a first data compute node (DCN) operating in a public datacenter. The method receives an encryption rule from a centralized network controller. The method determines that the network encryption rule requires encryption of packets between second and third DCNs operating in the public datacenter. The method requests a first key from a secure key storage. Upon receipt of the first key, the method uses the first key and additional parameters to generate second and third keys. The method distributes the second key to the second DCN and the third key to the third DCN in the public datacenter.
    Type: Grant
    Filed: September 9, 2023
    Date of Patent: December 2, 2025
    Assignee: VMware LLC
    Inventors: Ganesan Chandrashekhar, Mukesh Hira, Su Wang, Akshay Katrekar
  • Publication number: 20250257390
    Abstract: The present disclosure relates in some aspects to methods, systems, and kits for analyzing a biological sample comprising generating a rolling circle amplification product (RCP) using a target ribonucleic acid (RNA) as a primer. In some aspects, RNase H and a nucleic acid oligonucleotide are used to generate a free 3? end of the target RNA to prime RCA.
    Type: Application
    Filed: May 1, 2025
    Publication date: August 14, 2025
    Inventors: Su WANG, Robert HENLEY
  • Publication number: 20250232026
    Abstract: The present disclosure provides a processing method of a remote attestation report, a database service end and a database client end. The method includes: acquiring a request statement related to a remote attestation report from a database client end; executing a preset function corresponding to the request statement to call an interface of a first TEE remote attestation SDK to obtain a processing result related to the remote attestation report; sending the processing result to the database client end. Embodiments of the present disclosure can reduce the difficulty in the development and application of a remote attestation function.
    Type: Application
    Filed: May 31, 2023
    Publication date: July 17, 2025
    Inventors: Su WANG, Fang LU, Yufei MAI
  • Publication number: 20250208894
    Abstract: The present disclosure provides a data processing method, an apparatus, a device and a storage medium. The method includes: providing a standard data storage interface for an application program by adopting a storage client end running in a first virtual machine; receiving a data read-write request sent by the application program through the standard data storage interface; forwarding the data read-write request to a storage service end running in a second virtual machine, so that the storage service end returns a data read-write response result according to the data read-write request, where the first virtual machine is isolated from the second virtual machine. A universal and easy-to-use solution is provided for implementing a universal persistent storage of an application program in the virtualized trusted isolated space scenario, and the data processing cost can be greatly reduced.
    Type: Application
    Filed: March 9, 2023
    Publication date: June 26, 2025
    Inventors: Yufei MAI, Fang LU, Su WANG
  • Publication number: 20250190542
    Abstract: A virtualization-based trusted computing measurement method and apparatus, a device, and a storage medium. The method comprises: determining an application program to be measured; separating target measurement data from the application program, and storing the target measurement data into a virtual image file of a virtual machine, the virtual machine comprising a trusted execution environment; determining the credibility of a target virtual image file loaded to the trusted execution environment; and according to the credibility of the target virtual image file, allowing or forbidding an application program corresponding to the target virtual image file to operate in the trusted execution environment. In the embodiments of the present application, fine-grained trusted computing measurement may be performed on the application program, thereby better providing a service on the basis of the fine-grained measurement result.
    Type: Application
    Filed: February 20, 2023
    Publication date: June 12, 2025
    Applicant: Cloud Intelligence Assets Holding (Singapore) Private Limited
    Inventors: Yufei MAI, Fang LU, Su WANG
  • Patent number: 12319956
    Abstract: The present disclosure relates in some aspects to methods, systems, and kits for analyzing a biological sample comprising generating a rolling circle amplification product (RCP) using a target ribonucleic acid (RNA) as a primer. In some aspects, RNase H and a nucleic acid oligonucleotide are used to generate a free 3? end of the target RNA to prime RCA.
    Type: Grant
    Filed: July 30, 2024
    Date of Patent: June 3, 2025
    Assignee: 10x Genomics, Inc.
    Inventors: Su Wang, Robert Henley
  • Publication number: 20250090686
    Abstract: Compositions and methods for treating Duchenne Muscular Dystrophy (DMD) and excising small portions of exons 44, 50, and 53 of the DMD gene are encompassed.
    Type: Application
    Filed: September 6, 2024
    Publication date: March 20, 2025
    Applicant: Vertex Pharmaceuticals Incorporated
    Inventors: Tudor Fulga, Yurong Xin, Yi-Li Min, Foram Ashar, Su Wang, Jianming Liu, Yang Guo, D'anna Nelson
  • Publication number: 20250043339
    Abstract: The present disclosure relates in some aspects to methods, systems, and kits for analyzing a biological sample comprising generating a rolling circle amplification product (RCP) using a target ribonucleic acid (RNA) as a primer. In some aspects, RNase H and a nucleic acid oligonucleotide are used to generate a free 3? end of the target RNA to prime RCA.
    Type: Application
    Filed: July 30, 2024
    Publication date: February 6, 2025
    Inventors: Su WANG, Robert HENLEY
  • Publication number: 20250019653
    Abstract: The present disclosure relates to a preparation of CD140a/PDGFR? positive cells that comprises oligodendrocyte progenitor cells co-expressing OLIG2 and CD140a/PDGFR?. The preparation of cells is derived from pluripotent cells that were derived from skin cells, fibroblasts, umbilical cord blood, peripheral blood, bone marrow, or other somatic cells. The cell preparation has an in vivo myelination efficiency that is equal to or greater than the in vivo myelination efficiency of a preparation of A2B5+/PSA-NCAM? sorted fetal human tissue derived oligodendrocyte progenitor cells. Methods of making, isolating and using the disclosed cell preparation are also described.
    Type: Application
    Filed: September 25, 2024
    Publication date: January 16, 2025
    Applicant: University of Rochester
    Inventors: Steven A. Goldman, Su Wang
  • Publication number: 20250021002
    Abstract: Disclosed in the present invention are a bottom anti-reflective coating for deep ultraviolet lithography, a preparation method therefor and the use thereof. A polymer disclosed in the present invention is prepared by the following method: (1) preheating a solvent I; (2) mixing a monomer as shown in formula (A), a monomer as shown in formula (B), a monomer as shown in formula (C), a cross-linking agent as shown in formula (L), and an initiator and a solvent II to obtain a mixed solution; and (3) adding the mixed solution to a preheated solvent and perform a polymerization reaction, wherein step (1) and step (2) are in no particular order. The bottom anti-reflective coating for deep ultraviolet lithography can reduce the reflectivity, and after the bottom anti-reflective coating is spin-coated with a photoresist, no scum formed by the bottom anti-reflective coating is observed.
    Type: Application
    Filed: November 30, 2021
    Publication date: January 16, 2025
    Inventors: Shunong FANG, Su WANG, Zhiyue GENG
  • Publication number: 20250013149
    Abstract: An additive for 193 nm dry photoresist and a preparation method for and application of the additive. The structure of the additive is as shown in formula I, the weight-average molecular weight is 1000-3000, and the ratio of the weight-average molecular weight to the number-average molecular weight is 1-5. By using the additive, photoresist can form a photoresist film micropattern having excellent sensitivity and high resolution.
    Type: Application
    Filed: December 31, 2021
    Publication date: January 9, 2025
    Inventors: Shunong FANG, Su WANG, Zhiyue GENG, Zhongyue CUI
  • Publication number: 20240415984
    Abstract: Compositions and methods for treating Duchenne Muscular Dystrophy (DMD) and excising small portions of exons of the DMD gene are encompassed.
    Type: Application
    Filed: September 6, 2024
    Publication date: December 19, 2024
    Applicant: Vertex Pharmaceuticals Incorporated
    Inventors: Tudor Fulga, Yi-Li Min, Foram Ashar, Su Wang, Jianming Liu
  • Patent number: 12129484
    Abstract: The present disclosure relates to a preparation of CD140a/PDGFR? positive cells that comprises oligodendrocyte progenitor cells co-expressing OLIG2 and CD140a/PDGFR?. The preparation of cells is derived from pluripotent cells that were derived from skin cells, fibroblasts, umbilical cord blood, peripheral blood, bone marrow, or other somatic cells. The cell preparation has an in vivo myelination efficiency that is equal to or greater than the in vivo myelination efficiency of a preparation of A2B5+/PSA-NCAM? sorted fetal human tissue derived oligodendrocyte progenitor cells. Methods of making, isolating and using the disclosed cell preparation are also described.
    Type: Grant
    Filed: October 21, 2019
    Date of Patent: October 29, 2024
    Assignee: University of Rochester
    Inventors: Steven A. Goldman, Su Wang
  • Publication number: 20240351979
    Abstract: Disclosed in the present invention are a polyonium salt photoacid generator for ArF light source dry lithography, and a preparation method therefor and an application thereof. The photoacid generator is an onium salt having an anions and an onium ion, the anion having a structure as shown in formula (I), the onium ion having a structure shown in formula (A) or formula (B), and the number of onium ions keeping the charge of the onium salt neutral. A photoresist comprising the onium salt of the present invention has better resolution, sensitivity and linewidth roughness.
    Type: Application
    Filed: October 19, 2021
    Publication date: October 24, 2024
    Inventors: Shunong FANG, Su WANG, Zhiyue GENG
  • Patent number: 12091375
    Abstract: Disclosed is a preparation method for triphenylchloromethane, comprising the following steps: adding hydrochloric acid or a mixture of hydrochloric acid and Lewis acid to a mixture of triphenylmethanol and an organic solvent; stirring for reaction; removing the water layer after the completion of reaction to obtain an organic solution containing triphenylchloromethane. In the method, the conversion rate of triphenylmethanol is almost quantitative to be above 99%, and the content of triphenylchloromethane in the product obtained is above 99%. The operation is simple, and no waste gas is generated. Therefore, the method is environmentally friendly and suitable for industrialized production and can achieve better economic benefits.
    Type: Grant
    Filed: January 6, 2020
    Date of Patent: September 17, 2024
    Assignees: Linhai Huanan Chemical Co., Ltd., Zhejiang Huahai Pharmaceutical Co., Ltd.
    Inventors: Lu Zhang, Guoliang Tu, Jianyue Xu, Heping Jin, Su Wang, Qi Hu, Sen Yang, Heng Liu
  • Publication number: 20240302749
    Abstract: A resin, and an ArF dry photoresist composition comprising same and an application. The resin is obtained by polymerizing the following monomers in parts by weight: 40-47.5 parts of a monomer (A), 0.5-5 parts of a monomer (B), 0.25-2.5 parts of a monomer (C), and 0.25-2.5 parts of a monomer (D). A photoresist comprising the resin has the advantages of being high in resolution, high in sensitivity, and low in line width roughness.
    Type: Application
    Filed: April 17, 2024
    Publication date: September 12, 2024
    Inventors: Su WANG, Shunong FANG, Sen XU, Yiming LIN
  • Patent number: 12074731
    Abstract: Some embodiments provide a centralized overlay-network cloud gateway and a set of centralized services in a transit virtual cloud network (VCN) connected to multiple other compute VCNs hosting compute nodes (VMs, containers, etc.) that are part of (belong to) the overlay network. The centralized overlay-network cloud gateway provides connectivity between compute nodes of the overlay network (e.g., a logical network spanning multiple VCNs) and compute nodes in external networks. Some embodiments use the centralized overlay-network cloud gateway to provide transitive routing (e.g., routing through a transit VCN) in the absence of direct peering between source and destination VCNs. The overlay network, of some embodiments, uses the same subnetting and default gateway address for each compute node as the cloud provider network provided by the virtual private cloud provider.
    Type: Grant
    Filed: June 26, 2022
    Date of Patent: August 27, 2024
    Assignee: VMware LLC
    Inventors: Mukesh Hira, Su Wang, Rahul Jain, Ganesan Chandrashekhar, Sandeep Siroya